Discover the complete record of transactions filed by Anders Jack, Autre. Director active across 1 companies, notably Revolution Medicines, Inc.. In total, 9 filings have been published. Total volume traded: €34k. The latest transaction was disclosed on 17 June 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Jack Anders is associated with Revolution Medicines, Inc. His role is specified in the remarks, where he contributes to the company's strategy and operations. His expertise in the pharmaceutical field is an asset for the development of Revolution Medicines.